VERISIAN
LIVE

Serial Number

99607738

Owner

Verisian Ltd

Attorney

Parna A. Mehrbani

Filing Date

Jan 21, 2026

Add to watchlist:

No watchlists yet
View on USPTO

VERISIAN Trademark

Serial Number: 99607738

VERISIAN is a trademark filed by Verisian Ltd on January 21, 2026. The trademark is classified under Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently pending registration.

Owner Contact Info

Verisian Ltd (2 trademarks)

86–90 Paul Street, 3rd Floor
London, England EC2A 4NE , GB

Entity Type: 99

Trademark Details

Filing Date

January 21, 2026

Registration Date

Not Registered

Goods & Services

Scientific and technological services relating to clinical research; software development for trial data analysis and validation; Scientific research and analysis services in the field of pharmaceuticals and biotechnology; Preparation of scientific reports; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Scientific research for medical purposes; Provision of scientific information; Software development tools for clinical research; Programming software for importing and managing data; Data management and analytics services for clinical trials; Software as a service (SaaS) featuring software incorporating artificial intelligence (AI) tools for data validation, data analytics, machine learning and artificial intelligence; Software as a service (SaaS) featuring software for clinical trial analysis; Software as a service (SaaS) featuring software for data validation and regulatory submission; Development of databases used in clinical research and data validation; Development, updating and maintenance of artificial intelligence (AI) software and database systems; Development of programmes for data processing; Pharmaceutical research and development; Development of data programs in respect of clinical trial analysis; Technical data analysis; Design and development of computer software for evaluation and calculation of data; Design and development of computer software for regulatory submissions; Data validation services in relation to clinical research; Provision of online platforms for monitoring and reviewing clinical studies; Consultancy services in the field of clinical trial data standardisation and compliance; Consultancy services in the field of drug development and medical research; Consultancy services in the field of clinical research; Scientific validation and oversight for clinical research and trials; Providing information relating to drug development; Provision of information relating to clinical studies and treatments; Consultancy in the field of pharmaceutical research

Consultancy services in relation to medical regulatory reviews; Medical regulatory review services; Medical analysis services relating to the treatment and validation of clinical trial data; Medical information services provided via digital platforms; Issuing and compilation of medical reports; Monitoring of medical data for medical diagnosis and treatment; Providing pharmaceutical information; Provision of medical data analysis services for diagnostic and treatment purposes; Medical data analysis and validation services to support regulatory submissions and approval; Preparation of medical reports based on biometric and clinical data; Advisory services relating to patient access to clinical innovations; Support services for public health authorities in evaluating medical data

Filing History

NOTIFICATION OF NON-FINAL ACTION E-MAILED
May 21, 2026 GNRN
NON-FINAL ACTION E-MAILED
May 21, 2026 GNRT
NON-FINAL ACTION WRITTEN
May 21, 2026 CNRT
ASSIGNED TO EXAMINER
May 19, 2026 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 11, 2026 NWOS
APPLICATION FILING RECEIPT MAILED
Jan 21, 2026 MAFR
NEW APPLICATION ENTERED
Jan 21, 2026 NWAP